Form D/A - Notice of Exempt Offering of Securities: [Amend]
SEC Accession No. 0001836891-21-000002
Filing Date
2021-06-22
Accepted
2021-06-22 15:24:27
Documents
1
Effectiveness Date
2021-06-22
Items
Item 06b:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D/A  
1 primary_doc.xml D/A 10363
  Complete submission text file 0001836891-21-000002.txt   11393
Mailing Address 321 DEDALERA DR. PORTOLA VALLEY CA 94028
Business Address 321 DEDALERA DR. PORTOLA VALLEY CA 94028 650-575-1702
Angarus Therapeutics, Inc. (Filer) CIK: 0001836891 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: D/A | Act: 33 | File No.: 021-384604 | Film No.: 211034669